Aim higher


Production of LAMinin-521™ coated MICrocarriers for stem cell expansion (LAMMIC)

Sialylated antigens as immune tolerance inducers: an innovative therapeutic vaccine for MS.

Development of Affibody based radioimmunotherapy for treatment of multiple myeloma

A novel, topical drug for treatment of diabetic foot infections (DFI)

Dual Affinity Protein (DAP) technology for single-use affinity purification of antibodies

Improved diagnosis of lyme disease patients through identification of Borrelia-specific T-cells

Development of novel Hot-Start (HS) polymerase technologies for the Polymerase Chain Reaction (PCR)

Synthetic scaffolds for peptide stabilization and drug delivery

Rationalized Tailored Targeted Therapy for Cancer: The Triple-T Service

A unique tolerance inducing therapy for the treatment of the Orphan disease Myasthenia Gravis (MG)